+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars And Biosuperiors Market Research Reports

Etanercept- Biosimilar Insight, 2022 - Product Thumbnail Image

Etanercept- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Follitropin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Follitropin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pegfilgrastim- Biosimilar Insight, 2022 - Product Thumbnail Image

Pegfilgrastim- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Teriparatide- Biosimilar Insight, 2022 - Product Thumbnail Image

Teriparatide- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Biobetter Market - Forecasts from 2019 to 2024 - Product Thumbnail Image

Biobetter Market - Forecasts from 2019 to 2024

  • Report
  • December 2019
  • 120 Pages
  • Global
From
Global Biosimilars Market - Forecasts From 2018 to 2023 - Product Thumbnail Image

Global Biosimilars Market - Forecasts From 2018 to 2023

  • Report
  • November 2018
  • 110 Pages
  • Global
From
From
Biosimilar Commercial Strategies and Tactics - Product Thumbnail Image

Biosimilar Commercial Strategies and Tactics

  • Report
  • May 2019
  • 67 Pages
  • Global
Biosimilar Insulin Market Access - Product Thumbnail Image

Biosimilar Insulin Market Access

  • Report
  • January 2018
  • 19 Pages
  • Global
From
Biosimilars Market Access in the EU - Product Thumbnail Image

Biosimilars Market Access in the EU

  • Report
  • January 2018
  • 137 Pages
  • Europe
From
Global Biosimilars Market 2023-2027 - Product Thumbnail Image

Global Biosimilars Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
From
Prescriber Opinions on Biosimilars in Immunology - Product Thumbnail Image

Prescriber Opinions on Biosimilars in Immunology

  • Report
  • March 2021
  • 45 Pages
  • Global
From
Biosimilars in Immunology - Product Thumbnail Image

Biosimilars in Immunology

  • Report
  • February 2020
  • 137 Pages
  • Global
From
From
Biosimilars in Oncology - Product Thumbnail Image

Biosimilars in Oncology

  • Report
  • August 2018
  • 154 Pages
  • Global
From
Loading Indicator

The Biosimilars and Biosuperiors market is a rapidly growing sector of the pharmaceutical industry. Biosimilars are biologic drugs that are highly similar to an existing biologic drug, while biosuperiors are biologic drugs that are more effective than an existing biologic drug. Biosimilars and biosuperiors are used to treat a variety of conditions, including cancer, autoimmune diseases, and inflammatory diseases. Biosimilars and biosuperiors are developed using advanced biotechnology techniques, such as recombinant DNA technology and monoclonal antibody technology. These drugs are designed to be more cost-effective than their original counterparts, while still providing the same therapeutic benefits. The Biosimilars and Biosuperiors market is expected to continue to grow in the coming years, as more biologic drugs are developed and approved for use. Companies in this market include Amgen, Pfizer, Merck, and Novartis. Show Less Read more